Although their study focused on the antioxidant and anti-inflammatory activity of BCP, they suggested that activation of the CB2 receptor could play a crucial role in improving insulin sensitivity and regulating energy metabolism, fundamental aspects in the management of obesity and its comorbidities. The gene discussed is INS; the disease is obesity disorder.